Skip to main content

Table 2 Univariable logistic regression model of Neutrophil-lymphocyte ratio with regard to response to therapy (n = 247)

From: Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

Risk factor

β

Odds ratio (95 % CI)

p

Neutrophil-lymphocyte ratio (NLR)

0.087

1.091 (1.019-1.167)

0.012

  1. Abbreviations: CI confidence interval, β regression coefficient, response to therapy = Sinn score 1–4